Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
M
Michael D. Berquist
Researcher
Also affiliated: Apple (Israel) (2021); Western Michigan University (2014–2019); Northern Michigan University (2013–2015); University of Applied Management Studies (2024)
Faculty Researcher
11 h-index
42 pubs
377 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Michael D. Berquist's research program investigates the neurobiological and pharmacological underpinnings of substance use disorders and related conditions. His work frequently utilizes animal models, particularly rats and mice, to examine the effects of various drugs, including stimulants like methamphetamine, and central nervous system depressants such as ethanol and opioids.
Berquist's publications explore topics ranging from the impact of environmental factors like limited bedding on ethanol consumption to the neuroinflammatory consequences of chronic ethanol administration. He also studies the interaction of different drug compounds, such as buprenorphine and norbuprenorphine, and investigates the potential therapeutic applications of monoclonal antibodies for treating methamphetamine use. His collaborations include work with Lisa K. Brents, Brian J. Parks, and Julia Tobacyk at the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications.
Metrics
- h-index: 11
- Publications: 42
- Citations: 377
Selected Publications
-
Interoceptive effects of N1-substituted lysergamides in rats: role of agonist affinity at 5-HT receptors and in vivo metabolism to lysergic acid diethylamide (LSD) (2026)
-
Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine (2025)
-
Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity (2024)
-
Limited bedding and nesting increases ethanol drinking in female rats (2024)
-
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)
-
Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats (2023)
-
481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)
-
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. (2022)
-
Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation (2022)
-
Methamphetamine‐Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long‐Term Self‐Administration in Rats (2022)
-
Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception (2022)
-
Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long–Evans rats (2021)
-
Methamphetamine-Induced Open Field Behavior and LD50 in<i>Periplaneta americana</i>Cockroaches (Blattodea: Blattidae) (2020)
-
Effect of bile duct ligation-induced liver dysfunction on methamphetamine pharmacokinetics in male and female rats (2020)
-
Liver dysfunction effects on methamphetamine pharmacokinetics in male and female rats (2020)
Grants & Funding
As listed on this researcher's institutional profile.
- IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder NIH/Nat. Inst. on Drug Abuse via InterveXion Therapeutics, LLC
Collaboration Network
Top Collaborators
Brian J. Parks
University of Arkansas for Medical Sciences
6 shared publications
In database
- Limited bedding and nesting increases ethanol drinking in female rats
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
- Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
- 481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Showing 5 of 6 shared publications
Julia Tobacyk
University of Arkansas for Medical Sciences
6 shared publications
In database
- Limited bedding and nesting increases ethanol drinking in female rats
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
- Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
- 481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Showing 5 of 6 shared publications
Lisa K. Brents
University of Arkansas for Medical Sciences
6 shared publications
In database
- Limited bedding and nesting increases ethanol drinking in female rats
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
- Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
- 481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Showing 5 of 6 shared publications
Paloma Salazar
University of Arkansas for Medical Sciences (US)
5 shared publications
- Limited bedding and nesting increases ethanol drinking in female rats
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
- Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
- Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats
Madison McGraw
University of Arkansas for Medical Sciences
3 shared publications
In database
- Limited bedding and nesting increases ethanol drinking in female rats
- Methamphetamine‐Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long‐Term Self‐Administration in Rats
- Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats
Lori Coward
Samford University (US)
3 shared publications
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
- 481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Gregory S. Gorman
Samford University (US)
3 shared publications
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
- Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
- 481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Melinda G. Gunnell
InterveXion Therapeutics (United States)
3 shared publications
In database
- Limited bedding and nesting increases ethanol drinking in female rats
- Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity
- Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine
Ralph Henry
InterveXion Therapeutics (United States) (US)
2 shared publications
- Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity
- Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine
W. Brooks Gentry
University of Arkansas for Medical Sciences
2 shared publications
In database
- Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity
- Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine
Misty W. Stevens
2 shared publications
- Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity
- Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine
William E. Fantegrossi
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long–Evans rats
Lindsey L. Morrison
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception
Laura Osborn
University of Arkansas for Medical Sciences
1 shared publication
In database
- Methamphetamine‐Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long‐Term Self‐Administration in Rats
Madison Berg
University of Arkansas for Medical Sciences
1 shared publication
In database
- Methamphetamine‐Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long‐Term Self‐Administration in Rats
Similar Researchers
Based on overlapping research topics
Charles E. Hay
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Madison Berg
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
John T. Striednig
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Lauren R. Fitzgerald
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Brenda M. Gannon
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Brian J. Parks
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies